Information security incident occurred at Sun Pharma, impacted IT assets isolated
New Delhi: Drug major Sun Pharma has reported an "information security incident" at the company and said it is investigating the matter. The Mumbai-based company said the impacted IT assets have been isolated.
Sun Pharma is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra. The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies. It includes generics, branded generics, specialty, complex or difficult-to-make technology-intensive products, over-the-counter (OTC), antiretrovirals (ARVs), Active Pharmaceutical Ingredients (APIs), and Intermediates.
In 2020, drug makers Dr Reddy's Laboratories and Lupin had also reported cyber security breaches.
Read also: Sun Pharma Acquires Anti-inflammatory brand Phlogam from Aksigen Hospital Care
